A Systematic Review and Meta-analysis of HLA class II Associations in Patients with IgG4 Autoimmunity

Overview

Journal Sci Rep

Specialty Science

Date 2022 Jun 2

PMID 35654912

Authors

Anja Panhuber

Giovanni Lamorte

Veronica Bruno

Hakan Cetin

Wolfgang Bauer

Romana Hoftberger

Astrid C Erber

Florian Frommlet

Inga Koneczny

Affiliations

Soon will be listed here.

Abstract

Autoimmune diseases caused by pathogenic IgG4 subclass autoantibodies (IgG4-AID) include diseases like MuSK myasthenia gravis, pemphigus vulgaris or thrombotic thrombocytopenic purpura. Their etiology is still unknown. Polymorphisms in the human leukocyte antigen (HLA) gene locus, particularly in HLA-DRB1, are known genetic susceptibility factors for autoimmune diseases. We hypothesized a similar role for HLA polymorphisms in IgG4-AID and conducted a systematic review and meta-analysis with case-control studies on IgG4-AID based on MOOSE/ HuGENet guidelines. Genotype (G) and allele (A) frequencies of HLA-DQB1*05 (G: OR 3.8; 95% CI 2.44-5.9; p < 0.00001; A: OR 2.54; 95% CI 1.82-3.55; p < 0.00001) and HLA-DRB1*14 (G: OR 4.31; 95% CI 2.82-6.59; p < 0.00001; A: OR 4.78; 95% CI 3.52-6.49; p < 0.00001) and the HLA-DRB1*14-DQB1*05 haplotype (OR 6.3; 95% CI 3.28-12.09; p < 0.00001/OR 4.98; 95% CI 3.8-6.53; p < 0.00001) were increased while HLA-DRB1*13 (G: OR 0.48; 95% CI 0.34-0.68; p < 0.0001; A: OR 0.46; 95% CI 0.34-0.62; p < 0.00001) was decreased in IgG4-AID patients. In conclusion, the HLA-DQB1*05, HLA-DRB1*14 alleles and the HLA-DQB1*05-DRB1*14 haplotype could be genetic risk factors that predispose for the production of pathogenic IgG4 autoantibodies and the HLA-DRB1*13 allele may protect from IgG4 autoimmunity.

Citing Articles

The role of oxidative post-translational modifications in type 1 diabetes pathogenesis.

Alhamar G, Vinci C, Franzese V, Tramontana F, Le Goux N, Ludvigsson J Front Immunol. 2025; 16:1537405.

PMID: 40028329 PMC: 11868110. DOI: 10.3389/fimmu.2025.1537405.

HLA dependency and possible clinical relevance of intrathecally synthesized anti-IgLON5 IgG4 in anti-IgLON5 disease.

Koneczny I, Macher S, Hutterer M, Seifert-Held T, Berger-Sieczkowski E, Blaabjerg M Front Immunol. 2024; 15:1376456.

PMID: 38827736 PMC: 11141242. DOI: 10.3389/fimmu.2024.1376456.

A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression.

Koneczny I, Mane-Damas M, Zong S, de Haas S, Huda S, van Kruining D Front Immunol. 2024; 15:1325171.

PMID: 38715598 PMC: 11074957. DOI: 10.3389/fimmu.2024.1325171.

Toxin exposure and HLA alleles determine serum antibody binding to toxic shock syndrome toxin 1 (TSST-1) of .

Weiss S, Holtfreter S, Meyer T, Schmiedeke F, Cammann C, Dorr M Front Immunol. 2023; 14:1229562.

PMID: 37731490 PMC: 10507260. DOI: 10.3389/fimmu.2023.1229562.

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease.

Vakrakou A, Karachaliou E, Chroni E, Zouvelou V, Tzanetakos D, Salakou S Front Immunol. 2023; 14:1212757.

PMID: 37564637 PMC: 10410455. DOI: 10.3389/fimmu.2023.1212757.

References

Gonzalez-Escribano M, Jimenez G, Walter K, Montes M, Perez-Bernal A, Rodriguez M . Distribution of HLA class II alleles among Spanish patients with pemphigus vulgaris. Tissue Antigens. 1998; 52(3):275-8. DOI: 10.1111/j.1399-0039.1998.tb03043.x. View

Sakai K, Kuwana M, Tanaka H, Hosomichi K, Hasegawa A, Uyama H . HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DR. Blood. 2020; 135(26):2413-2419. DOI: 10.1182/blood.2020005395. View

Li S, Zhang Q, Wang P, Li J, Ni J, Wu J . Association between HLA-DQB1 polymorphisms and pemphigus vulgaris: A meta-analysis. Immunol Invest. 2017; 47(1):101-112. DOI: 10.1080/08820139.2017.1385622. View

Aversa G, Punnonen J, Cocks B, de Waal Malefyt R, Vega Jr F, Zurawski S . An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J Exp Med. 1993; 178(6):2213-8. PMC: 2191286. DOI: 10.1084/jem.178.6.2213. View

Alvarenga M, do Carmo L, Vasconcelos C, Papais Alvarenga M, Alvarenga-Filho H, de Melo Bento C . Neuromyelitis optica is an HLA associated disease different from Multiple Sclerosis: a systematic review with meta-analysis. Sci Rep. 2021; 11(1):152. PMC: 7794341. DOI: 10.1038/s41598-020-80535-3. View

Zhang Q, Lin C, Dong Q, Wang J, Wang W . Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: a meta-analysis of non-family-based studies. Autoimmun Rev. 2011; 10(8):474-81. DOI: 10.1016/j.autrev.2011.03.003. View

Subbarayal B, Schiller D, Mobs C, de Jong N, Ebner C, Reider N . Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen. Allergy. 2013; 68(11):1377-86. DOI: 10.1111/all.12236. View

Boyle M, Berglund E, Murai K, Weber L, Peles E, Ranscht B . Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve. Neuron. 2001; 30(2):385-97. DOI: 10.1016/s0896-6273(01)00296-3. View

Punnonen J, Aversa G, Cocks B, McKenzie A, Menon S, Zurawski G . Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S A. 1993; 90(8):3730-4. PMC: 46375. DOI: 10.1073/pnas.90.8.3730. View

10.

Cruz-Tapias P, Perez-Fernandez O, Rojas-Villarraga A, Rodriguez-Rodriguez A, Arango M, Anaya J . Shared HLA Class II in Six Autoimmune Diseases in Latin America: A Meta-Analysis. Autoimmune Dis. 2012; 2012:569728. PMC: 3345213. DOI: 10.1155/2012/569728. View

11.

Moraes J, Moraes M, Fernandez-Vina M, Diaz L, Friedman H, Campbell I . HLA antigens and risk for development of pemphigus foliaceus (fogo selvagem) in endemic areas of Brazil. Immunogenetics. 1991; 33(5-6):388-91. DOI: 10.1007/BF00216698. View

12.

Brochado M, Nascimento D, Campos W, Deghaide N, Donadi E, Roselino A . Differential HLA class I and class II associations in pemphigus foliaceus and pemphigus vulgaris patients from a prevalent Southeastern Brazilian region. J Autoimmun. 2016; 72:19-24. DOI: 10.1016/j.jaut.2016.04.007. View

13.

Satoguina J, Adjobimey T, Arndts K, Hoch J, Oldenburg J, Layland L . Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-beta. Eur J Immunol. 2008; 38(11):3101-13. DOI: 10.1002/eji.200838193. View

14.

Hong Y, Li H, Romi F, Skeie G, Gilhus N . HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis. Acta Neurol Scand. 2018; 138(3):219-226. DOI: 10.1111/ane.12951. View

15.

Lighaam L, Rispens T . The Immunobiology of Immunoglobulin G4. Semin Liver Dis. 2016; 36(3):200-15. DOI: 10.1055/s-0036-1584322. View

16.

Sinkovits G, Szilagyi A, Farkas P, Inotai D, Szilvasi A, Tordai A . The role of human leukocyte antigen DRB1-DQB1 haplotypes in the susceptibility to acquired idiopathic thrombotic thrombocytopenic purpura. Hum Immunol. 2016; 78(2):80-87. DOI: 10.1016/j.humimm.2016.11.005. View

17.

Saha M, Harman K, Mortimer N, Binda V, Black M, Kondeatis E . Pemphigus vulgaris in White Europeans is linked with HLA Class II allele HLA DRB1*1454 but not DRB1*1401. J Invest Dermatol. 2009; 130(1):311-4. DOI: 10.1038/jid.2009.241. View

18.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

19.

Lombardi M, Mercuro O, Tecame G, Fusco C, Ruocco V, Salerno A . Molecular analysis of HLA DRB1 and DQB1 in Italian patients with pemphigus vulgaris. Tissue Antigens. 1996; 47(3):228-30. DOI: 10.1111/j.1399-0039.1996.tb02545.x. View

20.

Miyagawa S, Higashimine I, Iida T, Yamashina Y, Fukumoto T, Shirai T . HLA-DRB1*04 and DRB1*14 alleles are associated with susceptibility to pemphigus among Japanese. J Invest Dermatol. 1997; 109(5):615-8. DOI: 10.1111/1523-1747.ep12337585. View